Gross Profit Analysis: Comparing Jazz Pharmaceuticals plc and Bausch Health Companies Inc.

Jazz vs. Bausch: A Decade of Gross Profit Trends

__timestampBausch Health Companies Inc.Jazz Pharmaceuticals plc
Wednesday, January 1, 201460089000001055457000
Thursday, January 1, 201578538000001222277000
Friday, January 1, 201670630000001382587000
Sunday, January 1, 201761760000001508505000
Monday, January 1, 201860290000001769378000
Tuesday, January 1, 201962510000002033831000
Wednesday, January 1, 202057780000002214650000
Friday, January 1, 202160400000002653478000
Saturday, January 1, 202257600000003118857000
Sunday, January 1, 202361980000003398627000
Loading chart...

Igniting the spark of knowledge

Gross Profit Trends: Jazz Pharmaceuticals vs. Bausch Health

In the ever-evolving pharmaceutical industry, understanding financial health is crucial. This analysis compares the gross profit trends of Jazz Pharmaceuticals plc and Bausch Health Companies Inc. from 2014 to 2023. Over this period, Jazz Pharmaceuticals has shown a remarkable growth trajectory, with its gross profit increasing by over 220%, from approximately $1.06 billion in 2014 to $3.40 billion in 2023. In contrast, Bausch Health's gross profit has experienced fluctuations, peaking in 2015 at around $7.85 billion, but generally maintaining a steady range around $6 billion. This comparison highlights Jazz Pharmaceuticals' robust growth strategy, while Bausch Health's performance reflects a more stable, albeit less dynamic, financial path. As the pharmaceutical landscape continues to shift, these insights provide a window into the strategic directions of these two industry players.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025